Live Breaking News & Updates on Nitiation

Stay informed with the latest breaking news from Nitiation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nitiation and stay connected to the pulse of your community

West Vault Mining Inc.: West Vault Mining Announces Coverage Initiation on Hasbrouck Gold Project by Kaiser Research


Vancouver, British Columbia--(Newsfile Corp. - April 26, 2023) - West Vault Mining Inc. (TSXV: WVM) (OTCQX: WVMDF) ("West Vault" or the "Company") is pleased to announce that Kaiser Research Online ("KRO")

Reno , Nevada , United-states , Vancouver , British-columbia , Canada , Three-hills , Alberta , Esmeralda-county , United-kingdom , British , Sandy-mcveyp-eng

Siemens Energy : 2023 should show some turnaround but SGRE's woes will weigh on profitability

INITIATION COV.We initiate coverage of Siemens Energy, which was spun off from Siemens AG in 2020 and is a global player in the energy business. The group recently acquired the remaining shares in... | April 18, 2023

Siemens-energy-ag-stock-exchange , Ews , Nformation , Ress-release , Nitiation , Nitiate , Overage , F , Iemens , Hich , As

Merck KGaA: Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients

Germany , Canada , United-states , Drug-administration , Merck-kgaa , Serono , Merck-kga , Data-monitoring-committee , Independent-data-monitoring-committee , Merck , Gaa

Merck: Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients on evobrutinib and patients

United-states , Canada , Serono , Drug-administration , Data-monitoring-committee , Independent-data-monitoring-committee , Merck , Nitiation , Atients , Vobrutinib , Aused

STOREBRAND ASA - Temporary pause in Share Buyback Program in connection with the Annual General Meeting

In a stock exchange announcement of 29 March 2023, Storebrand notified the initiation of a tranche amounting to a maximum of NOK 500 million in the share buyback program . The Program was initiated in... | April 12, 2023

Norway , Storebrand , Nord-trøag , Oslo , Trond-finn-eriksen , Oslo-stock-exchange , Financial-supervisory-authority , Annual-general-meeting , Supervisory-authority , Finn-eriksen , Investor-relations , Storebrand-asa-stock-exchange

Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

– Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934 for PKU and... | March 29, 2023

Cambridge , Cambridgeshire , United-kingdom , Aoife-brennan , Dave-hava-as-head-of-research , European-medicines-agency , Exchange-commission , Nasdaq , Globenewswire-inc , Synlogic-inc , Drug-administration , Society-for-inherited-metabolic-disorders

Synlogic : Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates - Form 8-K

Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates


- Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023... | March 29, 2023

Cambridge , Cambridgeshire , United-kingdom , Aoife-brennan , European-medicines-agency , Society-for-inherited-metabolic-disorders , Dave-hava-as-head-of-research , Synlogic-inc , Drug-administration , Nasdaq , Exchange-commission , Synlogic-reports-fourth-quarter

MedinCell Announces the Initiation of Coverage of Its Stock by Portzamparc

Regulatory News: MedinCell (Paris:MEDCL): Entitled "Liberating blockbusters over the long term", the Portzamparc BNP Paribas Group report recommends the stock as a buy with a target price

David-heuz , Louis-victor-delouvrier-alban-dufumier , Bryan-garnier , Nicolas-merigeau , Corbion-euronext , Kepler-cheuvreux , Global-health , Melinda-gates-foundation , Euronext , Paribas-group , Head-of-communications , Regulatory-news

Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

RUBY-3, a basket study of povetacicept in autoimmune glomerulonephritis, has initiated patient enrollment; RUBY-4, a basket study of povetacicept in autoimmune cytopenias, targets initiation in Q2... | March 23, 2023

United-states , American , James-tumlin , Exchange-commission , Linkedin , List-of-company-publications , Alpine-immune-sciences-inc , American-academy-of-dermatology-annual-meeting-on , Securities-exchange , Alpine-immune-sciences , Nephronet-clinical-trials-consortium , Nasdaq